Published in Obesity and Diabetes Week, August 29th, 2005
A strong performance in the United States led to a 65% increase in net income during the second quarter. Net income available to common shareholders reached $1.98 million, or $0.12 per share (diluted), up from earnings of $1.2 million, or $0.07 per share (diluted) in the second quarter of 2004. Reliv's worldwide net sales increased 19%, reaching $28.5 million in the second quarter of 2005, compared to sales of $23.9 million in the second quarter of 2004.
For the first half of 2005, Reliv's net income...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week